Clostridium difficile infection in Tasmanian public hospitals 2006 - 2010

Healthcare Infection

Volumn 16, Issue 3, 2011, Pages 101-106

  Mitchell, Brett ^a,b,c   Ware, Chris ^a   McGregor, Alistair ^a   Brown, Saffron ^a   Wells, Anne ^a  

^a Department of Health and Human Services ^*  (Australia)

^b Tasmanian Infection Prevention and Control Unit   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRESCHOOL CHILD; PUBLIC HOSPITAL; SCHOOL CHILD;

EID: 80053431560     PISSN: 18355617     EISSN: 18355625     Source Type: Journal    
DOI: 10.1071/HI11009     Document Type: Article

References (24)

1. Kelly C, LaMont J. Clostridium difficile -more difficult than ever. N Engl J Med 2008; 359: 1932-40. doi:10.1056/NEJMra0707500
2. Zilberberg M, Shorr A, Kollef M. Increase in adult Clostridium difficile related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14: 929-31. doi:10.3201/eid1406. 071447 (Pubitemid 351838602)
3. Lawrence S, Puzniak L, Shadel B, Gillespie K, Kollef M, Mundy L. Clostridium difficile in the intensive care unit: Epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007; 28: 123-30. doi:10.1086/511793 (Pubitemid 46374151)
4. McGregor A, Riley T, VanGessel H. Clostridium difficile associated disease. In Cruickshank M, Ferguson J., editor. Reducing Harm to Patients from Healthcare Associated Infection: The Role of Surveillance. Sydney: Australian Commission on Safety and Quality in Healthcare; 2008.
5. Dial SMDM, Kezouh AP, Dascal AMD, Barkun AMDM, Suissa SP. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008; 179(8): 767-72.
6. Riley T.V. From obscurity to 'superbug' -The rise of Clostridium difficile. Healthc Infect 2010; 15: 59-61. doi:10.1071/HI10028
7. Mitchell B, McGregor A, Brown S. Clostridium difficile infection surveillance protocol V2.0.: Department of Health and Human Services; 2009 [cited 2010 1st June 2010]; Available from: Http://www.dhhs.tas.gov.au/health- and-wellbeing/public-and-environmen tal-health/related-topics/tasmanian- infection-prevention-and-control-unit/publications/CDI-Surveillance-Protocol-V2. 0-August-2009.pdf.
8. Australian Commission on Safety and Quality in Healthcare. Data Dictionary and Collection Guidelines for the Surveillance of Healthcare Associated Infections: Staphylococcus aureus bacteraemia & Clostridium difficile Infection. Australian Commission on Safety and Quality in Healthcare; 2010 [cited 2010 1st December]; V3.0: [Available from: Http://www.health.gov.au/ internet/safety/publishing.nsf/Content/com-pubs-HAI-NatSurv-Draft DataDic.
9. McDonald C, Coignard B, Dubberke E, Song X, Horan T, Kutty P. Recommendations for Surveillance of Clostridium difficile-Associated Disease. Infect Control Hosp Epidemiol 2007; 28(2): 140-5. doi:10.1086/511798 (Pubitemid 46374153)
10. Mitchell B, McGregor A. Microbiology laboratory testing for Clostridium difficile in Tasmania. In Ware C, editor. Hobart: Department of Health and Human Services; 2010.
11. Price MF, Dao-Tran T, Garey KW, Graham G, Gentry LO, Dhungana L, et al. Epidemiology and incidence of Clostridium difficileassociated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 2007; 65(1): 42-6. doi:10.1016/j.jhin.2006. 08.010 (Pubitemid 44932971)
12. Van Gessel H. Measuring the incidence of Clostridium difficileassociated diarrhoea in a group of Western Australian hospitals. Healthc Infect 2008; 13(2): 56-62. doi:10.1071/HI08010
13. Elliott B, Chang BJ, Golledge CL, Riley T.V. Clostridium difficileassociated diarrhoea. Intern Med J 2007; 37(8): 561-8. doi:10.1111/j.1445-5994.2007.01403.x (Pubitemid 47084173)
14. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353(23): 2442-9. doi:10.1056/NEJMoa051639 (Pubitemid 41770165)
15. Thomas C, Stevenson M, Williamson D, Riley T. Clostridium difficile associated diarrhoea: Epidemiological data from Western Australia associated with a modified antibiotics policy. Clin Infect Dis 2002; 35 (12): 1457-62. doi:10.1086/342691 (Pubitemid 36020687)
16. Sohn S, Climo M, Diekema D, Fraser V, Herwaldt L, Marino S, et al. Varying Rates of Clostridium difficile Associated Diarrhea at Prevention Epicenter Hospitals. Infect Control Hosp Epidemiol 2005; 26(8): 676-9. doi:10.1086/502601 (Pubitemid 41169735)
17. Health Protection Agency. Results of the mandatory Clostridium difficile reporting scheme -Acute Trust Counts and Rates by Quarter and Financial year-April 2007 onwards. London: Health Protection Agency; 2010 [cited 2010 3rd September 2010]; Available from: Http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 12789442340 25.
18. Van Gessel H, Riley T, McGregor A. Clostridiumdifficile infection: An update for infection control practitioners. Healthc Infect 2009; 14: 115-8. doi:10.1071/HI09105
19. Jarvis WR, Schlosser JA, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile inUS health care facility inpatients, 2008. Am J Infect Control 2009; 37(4): 263-70.
20. Lambert PJ, Dyck M, Thompson LH, Hammond GW. Population based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infect Control Hosp Epidemiol 2009; 30: 945-51.
21. Paltansing S, Van Den Berg RJ, Guseinova RA, Visser CE, Van Der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 2007; 13(11): 1058-64. (Pubitemid 47543105)
22. Asensio A, Vaque-Rafart J, Calbo-Torrecillas F, Gestal-Otero J, López-Fernández F, Trilla-Garcia A, Canton R. Increasing rates in Clostridium Difficile infection (CDI) among hospitalised patients, Spain 1999-2007. Eurosurveillance 2008; 13(31): 18 943.
23. Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R, et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: Results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007; 28(2): 131-9. (Pubitemid 46374152)
24. Health Protection Agency (2011). Voluntary surveillance of Clostridium difficile in England, Wales and Northern Ireland, 2010. http://www.hpa.org.uk/ web/HPAwebFile/HPAweb-C/12966812422 19.